Controls, Randomization & Blinding

Seeing an outcome after an intervention does not tell us what caused it.

People recover naturally. Symptoms fluctuate. expectations change reporting. Other treatments are added. Researchers make judgments. Participants differ before the study begins.

Controls, randomization and blinding are tools for separating the intervention from those alternatives.

A control provides a comparison

A treatment group without a comparator can tell us what happened after treatment.

It usually cannot tell us what would have happened without treatment.

A control group estimates that counterfactual more directly.

Depending on the question, controls may include:

• placebo;
• sham procedure;
• active comparator;
• no-treatment group;
• usual care;
• matched or contemporaneous comparison group.

The correct control depends on what alternative explanation the study is trying to rule out.

Randomization reduces selection bias

If participants or researchers choose who receives which treatment, groups may differ before treatment begins.

Those baseline differences can confound the outcome.

Random allocation helps balance both measured and unmeasured prognostic factors on average.

Randomization does not guarantee perfectly equal groups in every study.

Its strength is probabilistic: treatment assignment is not systematically determined by participant characteristics.

Allocation concealment happens before assignment

Randomization can be undermined if the upcoming assignment is predictable.

Allocation concealment prevents recruiters from knowing which treatment the next participant will receive.

This is different from blinding.

Concealment protects the assignment process.

Blinding protects later behavior and outcome assessment.

Blinding reduces information-driven bias

If participants know their treatment, expectations can affect behavior, symptom reporting or adherence.

If clinicians know, they may provide different co-interventions.

If outcome assessors know, subjective judgments can shift.

If analysts know group labels, analytic choices may be influenced.

Blinding is not always possible. Surgery, physical interventions and public-health policies may be obvious to participants or providers.

The question then becomes which sources of bias remain and how they were mitigated.

A placebo is not “nothing”

A placebo-controlled trial compares the treatment against the experience of receiving an intervention without its active component.

That can help separate:

• treatment-specific effects;
• expectation effects;
• natural change;
• regression toward the mean;
• nonspecific care effects.

The observed placebo-group change is not itself a single “placebo effect.” It contains several processes.

Controls do not make a study automatically good

A randomized trial can still have:

• poor measurement;
• high dropout;
• selective reporting;
• protocol deviations;
• inadequate sample size;
• inappropriate analysis;
• short follow-up;
• limited generalizability.

Design labels are starting points for appraisal, not verdicts.

When randomization is impossible

Many important questions cannot be randomized.

We cannot randomly assign people to harmful environmental exposures for decades.

Observational studies can still support causal inference when design, timing, confounding control and alternative explanations are handled carefully.

That is the subject of Correlation, Confounding & Causal Inference.

The practical reading checklist

For an intervention study, ask:

1. What was the comparator?
2. How was allocation generated?
3. Was assignment concealed?
4. Who was blinded?
5. Could knowledge of treatment change measurement or behavior?
6. Were groups analyzed as assigned?
7. How much missing data existed?
8. Were outcomes specified before results were known?

The purpose is not to worship randomized trials.

It is to understand which alternative explanations the design successfully removes — and which remain.